Unité de Fabrication des Médicaments S.A (BVMT:UMED)

Tunisia flag Tunisia · Delayed Price · Currency is TND
9.15
+0.05 (0.55%)
At close: Aug 15, 2025
0.55%
Market Cap292.80M
Revenue (ttm)147.68M
Net Income (ttm)19.37M
Shares Out32.00M
EPS (ttm)0.61
PE Ratio15.11
Forward PE13.66
Dividendn/a
Ex-Dividend Daten/a
Volume124,360
Average Volume86,915
Open9.10
Previous Close9.10
Day's Range8.99 - 9.20
52-Week Range6.83 - 9.60
Beta0.03
RSI57.67
Earnings DateSep 16, 2025

About BVMT:UMED

Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic medicines under the UNIMED brand in Tunisia, Africa, Asia, and Europe. The company offers Opthalmic, ENT, and inhalation solutions, infusion solutions, injectable fluids and penicillin, and cephalosporin powders, as well as vaigtaine products in approximately 40 presentations for various therapeutic classes. It manufactures medicines for third party laboratories principals. Unité de Fabrication des Médicaments S.A. was founded in 1989 and is based in So... [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 572
Stock Exchange Tunis Stock Exchange
Ticker Symbol UMED
Full Company Profile

Financial Performance

In 2024, BVMT:UMED's revenue was 147.68 million, an increase of 8.58% compared to the previous year's 136.00 million. Earnings were 19.37 million, an increase of 249.30%.

Financial Statements

News

There is no news available yet.